SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Axcella Health Inc. – ‘10-K’ for 12/31/22 – ‘EX-22.1’

On:  Thursday, 3/30/23, at 4:12pm ET   ·   For:  12/31/22   ·   Accession #:  1633070-23-7   ·   File #:  1-38901

Previous ‘10-K’:  ‘10-K’ on 3/30/22 for 12/31/21   ·   Latest ‘10-K’:  This Filing   ·   18 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 3/30/23  Axcella Health Inc.               10-K       12/31/22   85:8.1M

Annual Report   —   Form 10-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.96M 
 2: EX-22.1     Published Report re: Matters Submitted to a Vote    HTML     24K 
                of Security Holders                                              
 3: EX-23.1     Consent of Expert or Counsel                        HTML     22K 
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     28K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     27K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     25K 
12: R1          Cover Page                                          HTML     86K 
13: R2          Audit Information                                   HTML     28K 
14: R3          Consolidated Balance Sheets                         HTML    111K 
15: R4          Consolidated Balance Sheet (Parenthetical)          HTML     33K 
16: R5          Consolidated Statements of Operations and           HTML     88K 
                Comprehensive Loss                                               
17: R6          Consolidated Statements of Cash Flows               HTML    114K 
18: R7          Consolidated Statements of Stockholders' Equity     HTML     77K 
                (Deficit)                                                        
19: R8          Consolidated Statements of Stockholders' Equity     HTML     25K 
                (Deficit) (Parenthetical)                                        
20: R9          Nature of Business and Basis of Presentation        HTML     37K 
21: R10         Summary of Significant Accounting Policies          HTML     56K 
22: R11         Marketable Securities                               HTML     35K 
23: R12         Fair Value Measurements                             HTML     48K 
24: R13         Property and Equipment                              HTML     35K 
25: R14         Accrued Expenses and Other Current Liabilities      HTML     33K 
26: R15         Debt                                                HTML     41K 
27: R16         Convertible Notes                                   HTML     41K 
28: R17         Stockholders' Equity                                HTML     64K 
29: R18         Income Taxes                                        HTML     58K 
30: R19         Commitments and Contingencies                       HTML     42K 
31: R20         Net Loss Per Share                                  HTML     37K 
32: R21         401(k) PLAN                                         HTML     28K 
33: R22         Restructuring and Impairment Charges                HTML     42K 
34: R23         Related-Party Transactions                          HTML     26K 
35: R24         Subsequent Events                                   HTML     25K 
36: R25         Summary of Significant Accounting Policies          HTML     93K 
                (Policies)                                                       
37: R26         Summary of Significant Accounting Policies          HTML     37K 
                (Tables)                                                         
38: R27         Marketable Securities (Tables)                      HTML     36K 
39: R28         Fair Value Measurements (Tables)                    HTML     46K 
40: R29         Property and Equipment (Tables)                     HTML     37K 
41: R30         Accrued Expenses and Other Current Liabilities      HTML     33K 
                (Tables)                                                         
42: R31         Debt (Tables)                                       HTML     34K 
43: R32         Stockholders' Equity (Tables)                       HTML     65K 
44: R33         Income Taxes (Tables)                               HTML     53K 
45: R34         Commitments and Contingencies (Tables)              HTML     40K 
46: R35         Net Loss Per Share (Tables)                         HTML     39K 
47: R36         Restructuring and Impairment Charges (Tables)       HTML     42K 
48: R37         Nature of Business and Basis of Presentation        HTML     80K 
                (Details)                                                        
49: R38         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES -        HTML     27K 
                Narrative (Details)                                              
50: R39         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES -        HTML     35K 
                Schedule of Property and Equipment Useful Life                   
                (Details)                                                        
51: R40         MARKETABLE SECURITIES - Narrative (Details)         HTML     27K 
52: R41         MARKETABLE SECURITIES - Schedule of Securities by   HTML     34K 
                Type (Details)                                                   
53: R42         MARKETABLE SECURITIES - Schedule of Securities by   HTML     30K 
                Contractual Maturity (Details)                                   
54: R43         Fair Value Measurements (Details)                   HTML     39K 
55: R44         PROPERTY AND EQUIPMENT - Schedule of Property and   HTML     40K 
                Equipment (Details)                                              
56: R45         PROPERTY AND EQUIPMENT - Narrative (Details)        HTML     31K 
57: R46         Accrued Expenses and Other Current Liabilities      HTML     37K 
                (Details)                                                        
58: R47         DEBT - Schedule of Long-term Debt (Details)         HTML     32K 
59: R48         DEBT FINANCING - Narrative (Details)                HTML     59K 
60: R49         Convertible Notes (Details)                         HTML     50K 
61: R50         STOCKHOLDERS' EQUITY - Narrative (Details)          HTML     63K 
62: R51         STOCK-BASED COMPENSATION - Schedule of Stock        HTML     30K 
                Compensation Expense (Details)                                   
63: R52         STOCK-BASED COMPENSATION - Schedule of Fair Value   HTML     34K 
                Measurement Inputs (Details)                                     
64: R53         STOCK-BASED COMPENSATION - Schedule of Option       HTML     73K 
                Activity (Details)                                               
65: R54         STOCK-BASED COMPENSATION - Schedule of Restricted   HTML     47K 
                Stock Units (Details)                                            
66: R55         INCOME TAXES - Schedule of Effective Income Tax     HTML     42K 
                Rate (Details)                                                   
67: R56         INCOME TAXES - Schedule of Net Deferred Tax Assets  HTML     49K 
                (Details)                                                        
68: R57         INCOME TAXES - Narrative (Details)                  HTML     42K 
69: R58         COMMITMENTS AND CONTINGENCIES - Narrative           HTML     31K 
                (Details)                                                        
70: R59         COMMITMENTS AND CONTINGENCIES - Summary of Lease    HTML     38K 
                Cost (Details)                                                   
71: R60         COMMITMENTS AND CONTINGENCIES - Schedule of Future  HTML     41K 
                Minimum Lease Payments (Details)                                 
72: R61         NET LOSS PER SHARE - Schedule of Earnings Per       HTML     54K 
                Share, Basic and Diluted (Details)                               
73: R62         NET LOSS PER SHARE - Schedule of Anti-dilutive      HTML     33K 
                Securities (Details)                                             
74: R63         401(k) PLAN (Details)                               HTML     24K 
75: R64         Restructuring and Impairment Charges (Details)      HTML     39K 
76: R65         Restructuring and Impairment Charges - Schedule of  HTML     32K 
                Restructuring and Impairment Costs (Details)                     
77: R66         RESTRUCTURING CHARGES - Schedule of Changes in      HTML     31K 
                Employee Termination Liability (Details)                         
78: R67         RESTRUCTURING AND IMPAIRMENT CHARGES - Schedule of  HTML     29K 
                Operating Lease (Details)                                        
79: R68         Related-Party Transactions (Details)                HTML     34K 
80: R69         Subsequent Events (Details)                         HTML     29K 
83: XML         IDEA XML File -- Filing Summary                      XML    152K 
81: XML         XBRL Instance -- axla-20221231_htm                   XML    944K 
82: EXCEL       IDEA Workbook of Financial Reports                  XLSX    137K 
 8: EX-101.CAL  XBRL Calculations -- axla-20221231_cal               XML    171K 
 9: EX-101.DEF  XBRL Definitions -- axla-20221231_def                XML    399K 
10: EX-101.LAB  XBRL Labels -- axla-20221231_lab                     XML   1.37M 
11: EX-101.PRE  XBRL Presentations -- axla-20221231_pre              XML    836K 
 7: EX-101.SCH  XBRL Schema -- axla-20221231                         XSD    132K 
84: JSON        XBRL Instance as JSON Data -- MetaLinks              408±   628K 
85: ZIP         XBRL Zipped Folder -- 0001633070-23-000007-xbrl      Zip   1.07M 


‘EX-22.1’   —   Published Report re: Matters Submitted to a Vote of Security Holders


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Document  
Exhibit 21.1

List of Subsidiaries
SubsidiaryJurisdiction of incorporation or organization
Acora Nutrition LLCDelaware
Axcella Health Securities CorporationMassachusetts


18 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/17/23  Axcella Health Inc.               8-K:5,9     2/14/23   13:300K                                   Toppan Merrill/FA
11/01/22  Axcella Health Inc.               10-Q        9/30/22   71:6.3M
10/13/22  Axcella Health Inc.               8-K:1,5,8,910/10/22   13:518K                                   Toppan Merrill/FA
 9/23/22  Axcella Health Inc.               8-K:1,2,3,8 9/20/22   12:426K                                   Toppan Merrill/FA
 8/12/22  Axcella Health Inc.               10-Q        6/30/22   65:5.9M
 2/07/22  Axcella Health Inc.               8-K:5,9     2/07/22   12:323K                                   Toppan Merrill/FA
12/07/21  Axcella Health Inc.               8-K:5,9    12/01/21   12:309K                                   Toppan Merrill/FA
 9/07/21  Axcella Health Inc.               8-K:1,2,9   9/02/21   11:760K                                   Toppan Merrill/FA
 3/17/21  Axcella Health Inc.               10-K       12/31/20   78:7.1M
11/12/20  Axcella Health Inc.               10-Q        9/30/20   59:5.2M
 8/31/20  Axcella Health Inc.               8-K:1,9     8/28/20   11:236K                                   Toppan Merrill/FA
 5/08/20  Axcella Health Inc.               8-K:5,9     5/08/20    2:25K                                    Toppan Merrill/FA
 3/23/20  Axcella Health Inc.               10-K       12/31/19   74:9.1M
11/12/19  Axcella Health Inc.               10-Q        9/30/19   65:6.5M
 5/17/19  Axcella Health Inc.               8-K:5,9     5/13/19    5:451K                                   Toppan Merrill/FA
 5/06/19  Axcella Health Inc.               S-1/A                  7:5M                                     Toppan Merrill-FA
 4/30/19  Axcella Health Inc.               S-1/A                 21:8.1M                                   Toppan Merrill-FA
 4/12/19  Axcella Health Inc.               S-1                   14:5.6M                                   Toppan Merrill-FA
Top
Filing Submission 0001633070-23-000007   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., May 5, 11:27:55.2pm ET